Advanced Immunological Approach in COPD Exacerbation

NCT02417649 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

288

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

BIOLOGICAL: Placebo
BIOLOGICAL: Ismigen

Sponsor

Lallemand Pharma AG

Collaborators

[object Object]